期刊文献+

麦冬皂苷B通过Myt/Cdc2信号通路抑制H460细胞有丝分裂 被引量:7

Ophiopogonin-B inhibited cell mitosis by Myt/Cdc2 pathway in H460 cells
下载PDF
导出
摘要 目的探究麦冬皂苷B(ophiopogonin-B,OP-B)对非小细胞肺癌细胞株H460有丝分裂及细胞周期调控的相关分子机制。方法 TUNEL免疫组化法观察细胞核物质的变化;DAPI染色法观察细胞核形态的改变及有丝分裂的状态;Western blot法检测细胞周期调控相关的蛋白信号通路。结果形态学结果表明,10μmol·L^(-1)浓度的OP-B能明显抑制H460细胞的有丝分裂,蛋白水平的检测结果表明,OP-B能抑制cyclin D1、cyclin B1的表达,促进Myt的表达及Cdc2的磷酸化,抑制histone H3(Ser10)的磷酸化,同时能上调周期抑制性蛋白p21的表达。结论 OP-B通过Myt/Cdc2信号通路导致细胞周期停滞在G0/G_1期,从而抑制细胞的有丝分裂。 AimTo explore the effects of ophiopogonin B(OP B)on cell cycle and mitosis in non small cell lung cancer(NSCLC)H460cells in vitro and the underlying mechanisms.MethodsTUNEL immunohistochemical assay was used to detect the change of the nuclear matter.DAPI staining was used to detect the change of the nuclear morphology and the mitosis status.Meanwhile,Western blot was performed to determine the protein level of the proteins regulating cell cycle and mitosis.ResultsOP B significantly arrested cell cycle in G0/G1phase and inhibited the mitosis in H460cells at the concentration of10μmol·L-1.Meanwhile,it inhibited the protein level of cyclinD1,cyclinB1,and up regulated the expression of Myt and the phosphorylation level of Cdc2.ConclusionOP B inhibits cell mitosis in A549cells through Myt/Cdc2signaling pathway.
作者 胡澄 蒋日磊 郭园园 张旭 陈美娟 HU Cheng;JIANG Ri lei;GUO Yuan yuan;ZHANG Xu;CHEN Mei juan(School of Medicine and Life Sciences, Nanjing University of Chinese Medicine Nanjing210023, China;Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor Nanjing210023, China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2017年第12期1736-1739,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81503374) 江苏省自然科学基金资助项目(No BK20131415) 江苏省高校优势学科建设工程项目(PAPD) 欧盟第七框架项目(No PIRSESGA-2013-612589) 江苏省教育厅重点项目(No16KJA360001)
关键词 麦冬皂苷B 非小细胞肺癌 有丝分裂 细胞周期 Myt CDC2 ophiopogonin B non small cell lung cancer mitosis cell cycle Myt Cdc2
  • 相关文献

参考文献1

二级参考文献13

  • 1Verdecchia A, Francisci S, Brenner H, et al. Recent cancer sur- vival in Europe: a 2000-02 period analysis of EUROCARE-4 data [J]. Lancet Oncol, 2007, 8 (9) :784 -96.
  • 2Coleman M P, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, I995-2007 (the International Cancer Benchmarking Partnership - ) :an analysis of population-based cancer registry data[ J ]. Lan- cet, 2011,377 (9760) :127 -38.
  • 3Fried P, Wolf K. Turnout cell invasion and migration: diversity and escape mechanisms [ J ]. Nat Rev Cancer, 2003,3 (5) :362 - 74.
  • 4Cheng C Y, Hsieh H L, Hsiao L D, et al. PB-K/Akt/JNK/NF- kappaB is essential for MMP-9 expression and outgrowth in human limbal epithelial cells on intact amniotic membrane [ J ]. Stem Cell Res, 2012, 9:9-23.
  • 5Chen M, Du Y, Qui M, et al. Ophiopogonin B-induced autophagy in on-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway [J]. Oncol Rep, 2013, 29(2) :430 -6.
  • 6Kinch M S, Moore M B, Harpole D H. Predictive value of the E- phA2 receptor tyrosine kinase in lung cancer recurrence and sur- vival [J]. Clin Cancer Res, 2003, 9:613 -8.
  • 7Steeg P S. Tumor metastasis: mechanistic insights andclinical challenges [J]. Nat Med, 2006, 12:895-904.
  • 8Roy R, Yang J, Moses M A. Matrix metalloprotemases as novel biomarkers and potential therapeutic targets in human cancer [ J]. J Clin Oncol, 2009, 27:5287- 97.
  • 9Lu Z, Lu N, Li C, et al. Oroxylin A inhibits matrix metalloprotei- nase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling path- way[J]. Toxicol Lett, 2012, 209 (3) :211 -20.
  • 10Banvois B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and rela- tionship to tumor progression [ J ]. Biochim Biophys Acta, 2012, 1825 (1) :29-36.

共引文献13

同被引文献61

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部